Is Zalcitabine registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 0 valid registrations of Zalcitabine.

Is Zalcitabine approved by the US FDA?

Drugs@FDA lists 1 application product line for Zalcitabine, including HIVID (Discontinued).

Active substance

Zalcitabine

SFDA 2
US FDA 1

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
HIVID 0.375MG F.C TAB	0.375 mg	Film-coated tablet · Oral use	100 Blister	SAR 449.75	NCE · Prescription	ROCHE	Withdrawn by MAH · Not Marketed
HIVID 0.75MG F.C TAB	0.75 mg	Film-coated tablet · Oral use	100 Blister	SAR 762.35	NCE · Prescription	ROCHE	Withdrawn by MAH · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
HIVID	0.375MG; 0.75MG	tablet · oral	ROCHE	Discontinued	19 Jun 1992

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.